MDXG vs APOG vs AWI vs NAUT

For growth investors, MiMedx Group, Inc.

(MDXG) is the stronger pick with 20. 0% revenue growth year-over-year, versus 3. 2% for Apogee Enterprises, Inc. (APOG). MiMedx Group, Inc. (MDXG) offers the better valuation at 11. 5x trailing P/E (295. 2x forward), making it the more compelling value choice. Analysts rate MiMedx Group, Inc. (MDXG) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, MiMedx Group, Inc.

(MDXG) is the cheapest at 11. 5x versus Armstrong World Industries, Inc. at 23. 3x. On forward P/E, Apogee Enterprises, Inc. is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Armstrong World Industries, Inc.

(AWI) delivered a total return of +63. 0%, compared to -71. 3% for Nautilus Biotechnology, Inc. (NAUT). Over 10 years, the gap is even starker: AWI returned +330. 4% versus NAUT's -72. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Armstrong World Industries, Inc.

(AWI) is the lower-risk stock at 0. 82β versus Nautilus Biotechnology, Inc. 's 1. 82β — meaning NAUT is approximately 122% more volatile than AWI relative to the S&P 500. On balance sheet safety, MiMedx Group, Inc. (MDXG) carries a lower debt/equity ratio of 9% versus 59% for Armstrong World Industries, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MiMedx Group, Inc.

(MDXG) is pulling ahead at 20. 0% versus 3. 2% for Apogee Enterprises, Inc. (APOG). On earnings-per-share growth, the picture is similar: Armstrong World Industries, Inc. grew EPS 17. 6% year-over-year, compared to -35. 2% for Apogee Enterprises, Inc.. Over a 3-year CAGR, MDXG leads at 16. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Armstrong World Industries, Inc.

(AWI) is the more profitable company, earning 19. 0% net margin versus 0. 0% for Nautilus Biotechnology, Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AWI leads at 26. 6% versus 0. 0% for NAUT. At the gross margin level — before operating expenses — MDXG leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Apogee Enterprises, Inc.

(APOG) trades at 10. 6x forward P/E versus 295. 2x for MiMedx Group, Inc. — 284. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDXG: 171. 0% to $10. 00.

In this comparison, APOG (2.

8% yield), AWI (0. 8% yield) pay a dividend. MDXG, NAUT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Armstrong World Industries, Inc.

(AWI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 8% yield, +330. 4% 10Y return). Nautilus Biotechnology, Inc. (NAUT) carries a higher beta of 1. 82 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AWI: +330. 4%, NAUT: -72. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MDXG (Healthcare) and APOG (Industrials) and AWI (Industrials) and NAUT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MDXG is a small-cap high-growth stock; APOG is a small-cap deep-value stock; AWI is a small-cap quality compounder stock; NAUT is a small-cap quality compounder stock. APOG, AWI pay a dividend while MDXG, NAUT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.